We discovered that estrogen activates EMT in a subset of Brca1-deficient tumor cells that maintain epithelial features, and enhances the number of CSCs, promoting ER-negative basal-like tumor progression and metastasis. This evidence concerns the gene ESR1 and neoplasm.